fda warning letters bpc 157 Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157 Banned: Key Facts
Description
The catch is that a compounded drug product qualifies for these exemptions only if the bulk drug substance used to make it meets one of three criteria: (1) it complies with a USP or National Formulary monograph
This is one of the major reasons why people avoid intravenous injections since it is something they will be injecting themselves
This creates self-reinforcing echo chambers that blur the lines between the effects of the peptide and the effects of expectation
10.1016/0197-2456(95)00134-4 [DOI] [PubMed] [Google Scholar] Kim H.-I., Hyung W
